0 Yorumlar
0 hisse senetleri
130 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
- Please log in to like, share and comment!
- Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Is Estimated To Witness High Growth Owing To Rising Prevalence of ALS & Increasing R&D InvestmentsThe Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market is estimated to be valued at US$662.3 million in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period from 2023 to 2030, according to a new report published by Coherent Market Insights.Market Overview:The Amyotrophic Lateral Sclerosis (ALS) Treatment Market deals with the development and commercialization of...0 Yorumlar 0 hisse senetleri 1896 Views 0 önizleme
- Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Is Estimated To Witness High Growth Owing To Rising Prevalence of ALS & Increasing R&D InvestmentsThe Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market is estimated to be valued at US$662.3 million in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period from 2023 to 2030, according to a new report published by Coherent Market Insights.Market Overview:The Amyotrophic Lateral Sclerosis (ALS) Treatment Market deals with the development and commercialization of...0 Yorumlar 0 hisse senetleri 1807 Views 0 önizleme
- Neurodegenerative Disease Market Size, Share, Trends, Opportunities, Key Drivers and Growth ProspectusThe global Neurodegenerative Disease market size reached USD 52.03 billion in 2023. Looking forward, Analytica Global expects the market to reach USD 102.6 billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. Analytica Global Research newly added a research report on the Global Neurodegenerative Disease Market, which represents a study for the period from 2024 to...0 Yorumlar 0 hisse senetleri 582 Views 0 önizleme
- The Global Memantine Market Growth Is driven by rising prevalence of Alzheimer's diseaseThe memantine market overview involves neuroprotective properties of memantine for treatment of moderate to severe forms of Alzheimer's disease. Memantine is an NMDA receptor antagonist approved as an add-on therapy to cholinesterase inhibitors for patients with moderate to severe Alzheimer's disease. It regulates glutamate activity to inhibit neurotoxicity and protect neurons from...0 Yorumlar 0 hisse senetleri 667 Views 0 önizleme